We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SES:NYSESES AI Corporation Analysis

Data as of 2026-09-01 - not real-time

$0.52

Latest Price

9/10Risk

Risk Level: High

Executive Summary

SES AI Corporation is priced at $0.5197 and its moving averages line up in bearish order, the shorter trailing the longer. The last 30 days have lost 10.7%. With RSI at 40.7 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at $0.4930 up to resistance at $0.6780.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 390.7% above today's level. Revenue is growing at 43.8% on a -289.6% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 92.8%, a beta of 3.17 and a maximum drawdown of 85.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

WOBURN, Mass., July 20, 2026--SES AI Corporation "SES AI" NYSE: SES , a global leader in the development and...Stockhouse2monLost Money on SES AI Corporation SES ?WOBURN, Mass., August 13, 2026--SES AI Corporation "SES AI" NYSE: SES , a global leader in the development and...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.32
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.32
  • Analyst targets imply +390.7% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Negative profit margin of -289.6%
  • Analyst targets imply +390.7% versus the current price
  • Negative return on equity of -31.2%

Key Metrics & Analysis

Financial Health

Revenue Growth43.80%
Profit Margin-289.64%
P/E Ratio-3.6
ROE-31.15%
ROA-17.42%
Debt/Equity3.82
P/B Ratio1.0
Op. Cash Flow$-58335000
Free Cash Flow$-28215376

Technical Analysis

TrendBearish
RSI40.7
Support$0.49
Resistance$0.68
MA 20$0.55
MA 50$0.66
MA 200$1.32
MACDBullish
VolumeDecreasing
Fear & Greed Index93.07

Valuation

Target Price$2.55
Upside/Downside390.67%
GradeFair
TypeBlend

Risk Assessment

Beta3.17
Volatility92.81%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.